Antibiotic Use in a Cohort of Extremely Low Birth Weight Neonates: Focus on Off-Label Uses and Prescription Behaviour
In the last
decades, the survival of extremely low birth weight (ELBW) neonates (BW ≤ 1000
g) has improved dramatically due to advances in perinatal and neonatal care and
better understanding of their physiopathology. These neonates, characterized by
a great immaturity, are more exposed to risks to develop different morbidities
and in particular are vulnerable to bacterial and fungal infections.
Antibiotics are
medications used to fight infections caused by bacteria. Nowadays, a large
variability in the use of antibiotics for the treatment of suspected/confirmed
neonatal sepsis persists between different European Neonatal Intensive Care
Units (NICUs) and most agents are still used in an off-label (OL) manner. In
this paper, the authors aimed to analyze antibiotic prescriptions in a cohort
of extremely low birth weight neonates admitted to Italian level III Neonatal
intensive Care Units.
An online
questionnaire was used to collect detailed information for each newborn.
Antibiotic prescriptions were classified about their license status and
compared with British National Formulary for Children (BNFC) and with a
practical guide prepared by the Italian Society of Neonatology (ISN). Data were collected in a database and summarized using standard
descriptive methods.
During the study
period (May - July 2014) among 93 neonates admitted to 30 Italian Neonatal
intensive Care Units, 56 (60%) received at least an antibiotic (92
prescriptions in total). Ampicillin, gentamicin and vancomycin were the
antibiotics most commonly used for the prevention/treatment of bacterial
infections. 56/92 antibiotic prescriptions (61%) resulted off-label mainly
as regards dosing frequency, while 13 prescriptions (14%) regarded antibiotics
used in absence of specific indication for newborns (meropenem, imipenem,
piperacillin/tazobactam, clindamycin, clarithromycin). 50/56 neonates (89.3%)
received at least one off-label antibiotic prescription.
Differences have been observed in dosing regimens between current study and
recommendations contained in BNFC, while prescriptions adhered more
frequently to ISN indications.
In summary, our
results confirm the high prevalence of off-label antibiotic use in ELBW neonates and
underline a better adherence to indications based on clinical practice.
Article by Laura Cuzzolin and Rocco
Agostino, from Italy.
Full access: http://suo.im/4xw8iK
评论
发表评论